Can Gene Therapy Cure Blindness?
Since the approval of the first gene therapy for blindness, there has been a wave…
Since the approval of the first gene therapy for blindness, there has been a wave…
The biotech industry has often been criticized for its lack of gender diversity. While there…
Turning failure into success is a difficult but much needed skill in a high-risk industry…
Update (18/09/2018): Horama has increased the total raised in its Series B fundraising to €22.5M,…
French biotech Horama has treated the first patients with a gene therapy for retinitis pigmentosa…
Still catching up on news? We've picked out the most exciting things that happened besides…
Horama has been authorized to start a Phase I/II trial in France testing HORA-PDE6B, a…
Horama is developing gene therapies for several hereditary retinal dystrophies. It has now raised €4M…